Erythroplasia of Queyrat treated with topical 5-fluorouracil

An Bras Dermatol. 2016 Sep-Oct;91(5 suppl 1):42-44. doi: 10.1590/abd1806-4841.20164595.

Abstract

We report a 33-year-old male patient diagnosed with erythroplasia of Queyrat. The patient had an erythematous and eroded lesion affecting more than 50% of the glans associated with bleeding and local pain. Despite previous indication of penectomy, he was successfully treated with topical 5-fluorouracil.

Publication types

  • Case Reports

MeSH terms

  • Administration, Topical
  • Adult
  • Antimetabolites, Antineoplastic / administration & dosage*
  • Biopsy
  • Carcinoma in Situ / drug therapy*
  • Carcinoma in Situ / pathology
  • Carcinoma, Squamous Cell / drug therapy*
  • Carcinoma, Squamous Cell / pathology
  • Erythroplasia / drug therapy*
  • Erythroplasia / pathology
  • Fluorouracil / administration & dosage*
  • Humans
  • Male
  • Penile Neoplasms / drug therapy*
  • Penile Neoplasms / pathology
  • Penis / pathology
  • Time Factors
  • Treatment Outcome

Substances

  • Antimetabolites, Antineoplastic
  • Fluorouracil